LB
IMGN

Leo Brokerage’s Immunogen Inc IMGN Stock Holding History

Leo Brokerage’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		$472K Hold
25,000
– – 0.05% 187
2023
Q1 		$96K Buy
+25,000
New +$107K 0.01% 286
2022
Q2 		– Sell
-25,000
Closed -$119K – 264
2022
Q1 		$119K Buy
+25,000
New +$138K 0.02% 234

Other funds holding IMGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Leo Brokerage's IMGN Position: Q2 2023 in Review

Leo Brokerage held its Immunogen Inc (IMGN) position steady in Q2 2023 at 25,000 shares worth $472K. The position accounts for 0.05% of the portfolio, ranked #187.

Leo Brokerage first reported a position in IMGN in Q1 2022 and has held it in 3 quarters since. 266 funds tracked by Wall St. Rank hold IMGN as of Q2 2023.

  • Leo Brokerage held 25,000 shares of Immunogen Inc worth $472K as of Q2 2023.
  • Leo Brokerage left its Immunogen Inc share count unchanged in Q2 2023.
  • Immunogen Inc made up 0.05% of Leo Brokerage's portfolio in Q2 2023, its #187 holding.
  • Leo Brokerage first reported a position in Immunogen Inc in Q1 2022 and has held it in 3 quarters since.
  • 266 funds tracked by Wall St. Rank held Immunogen Inc as of Q2 2023.

Based on Leo Brokerage's 13F filing for Q2 2023, filed 25 Jul 2023.